Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 781

1.

Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.

Batawil N, Alkordy T.

Eur J Surg Oncol. 2014 Feb;40(2):182-6. doi: 10.1016/j.ejso.2013.11.015. Epub 2013 Dec 14.

PMID:
24373298
2.

The frequency of malignancy and the relationship between malignancy and ultrasonographic features of thyroid nodules with indeterminate cytology.

Tutuncu Y, Berker D, Isik S, Akbaba G, Ozuguz U, Kucukler FK, Göcmen E, Yalcın Y, Aydin Y, Guler S.

Endocrine. 2014 Feb;45(1):37-45. doi: 10.1007/s12020-013-9922-1. Epub 2013 Mar 17. Erratum in: Endocrine. 2014 Feb;45(1):160.

PMID:
23504651
3.

RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.

An JH, Song KH, Kim SK, Park KS, Yoo YB, Yang JH, Hwang TS, Kim DL.

Clin Endocrinol (Oxf). 2015 May;82(5):760-6. doi: 10.1111/cen.12579. Epub 2014 Nov 28.

PMID:
25109485
4.

Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients.

Rago T, Di Coscio G, Basolo F, Scutari M, Elisei R, Berti P, Miccoli P, Romani R, Faviana P, Pinchera A, Vitti P.

Clin Endocrinol (Oxf). 2007 Jan;66(1):13-20.

PMID:
17201796
5.

Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.

Lee JH, Han K, Kim EK, Moon HJ, Yoon JH, Park VY, Kwak JY.

Ann Otol Rhinol Laryngol. 2017 Sep;126(9):625-633. doi: 10.1177/0003489417719472. Epub 2017 Jul 18.

PMID:
28719972
6.

Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.

Sahin M, Gursoy A, Tutuncu NB, Guvener DN.

Clin Endocrinol (Oxf). 2006 Oct;65(4):514-8.

PMID:
16984245
7.

Role of cytological and ultrasonographic features in predicting the risk of malignancy in thyroid nodules with indeterminate cytology.

Saiegh L, Shechner C, Dickstein G, Sheikh-Ahmad M, Reut M, Odeh M, Toubi A, Bejar J.

Minerva Endocrinol. 2014 Mar;39(1):43-52.

PMID:
24513603
8.

Is an Increase in Thyroid Nodule Volume a Risk Factor for Malignancy?

Nakamura H, Hirokawa M, Ota H, Kihara M, Miya A, Miyauchi A.

Thyroid. 2015 Jul;25(7):804-11. doi: 10.1089/thy.2014.0567. Epub 2015 May 18.

PMID:
25872408
9.

The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?

Ajmal S, Rapoport S, Ramirez Batlle H, Mazzaglia PJ.

J Am Coll Surg. 2015 Jun;220(6):987-92. doi: 10.1016/j.jamcollsurg.2014.12.010. Epub 2014 Dec 15.

PMID:
25667137
10.

A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.

Macias CA, Arumugam D, Arlow RL, Eng OS, Lu SE, Javidian P, Davidov T, Trooskin SZ.

Ann Surg Oncol. 2015 May;22(5):1527-32. doi: 10.1245/s10434-014-4190-8. Epub 2014 Nov 12.

PMID:
25388058
11.

Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.

Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, Hong SJ.

Thyroid. 2013 Jun;23(6):703-8. doi: 10.1089/thy.2012.0426. Epub 2013 May 28.

PMID:
23544697
12.

The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.

Yoon JH, Kwak JY, Moon HJ, Kim MJ, Kim EK.

Thyroid. 2011 Sep;21(9):993-1000. doi: 10.1089/thy.2010.0458. Epub 2011 Aug 11.

PMID:
21834673
13.

Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.

Méndez W, Rodgers SE, Lew JI, Montano R, Solórzano CC.

Ann Surg Oncol. 2008 Sep;15(9):2487-92. doi: 10.1245/s10434-008-0052-6. Epub 2008 Jul 12.

PMID:
18622644
14.

A nomogram for predicting malignancy in thyroid nodules diagnosed as atypia of undetermined significance/follicular lesions of undetermined significance on fine needle aspiration.

Yoon JH, Lee HS, Kim EK, Moon HJ, Kwak JY.

Surgery. 2014 Jun;155(6):1006-13. doi: 10.1016/j.surg.2013.12.035. Epub 2014 Jan 3.

PMID:
24630147
15.
16.

Predictors of malignancy in patients with cytologically suspicious thyroid nodules.

Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC.

Thyroid. 2011 Nov;21(11):1191-8. doi: 10.1089/thy.2011.0146. Epub 2011 Oct 18.

17.

Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features.

Gulcelik NE, Gulcelik MA, Kuru B.

Arch Otolaryngol Head Neck Surg. 2008 Dec;134(12):1312-5. doi: 10.1001/archotol.134.12.1312.

PMID:
19075128
18.

Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?

Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, Lumbroso J, Travagli JP, Hartl D, Baudin E, Schlumberger M, Leboulleux S.

Thyroid. 2012 Feb;22(2):165-72. doi: 10.1089/thy.2011.0255. Epub 2012 Jan 18.

PMID:
22257371
19.

Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology.

Lin JD, Chao TC, Huang BY, Chen ST, Chang HY, Hsueh C.

Thyroid. 2005 Jul;15(7):708-17.

PMID:
16053388
20.

Fine-needle aspiration cytology of thyroid nodules--how well are we doing?

Cheung YS, Poon CM, Mak SM, Suen MW, Leong HT.

Hong Kong Med J. 2007 Feb;13(1):12-5.

Supplemental Content

Support Center